Search Results 2341-2350 of 13646 for monoclonal antibody
Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell ...
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help you fight infections by making antibodies ...
... antibodies (except 21 days for bevacizumab), or 4 weeks (or 5 half-lives, whichever is shorter) from other anti-tumor therapies. Contrast-enhanced head CT ...
Patients who have a positive donor-specific antibody within 90 days prior to Randomization confirmed via medical records. Patients whose body weight is more ...
* Prior treatment with antibody-drug conjugate with topoisomerase inhibitor. * Is a candidate to locoregional treatment with potential to induce complete or ...
Allergy or sensitivity to INBRX-109 or known allergies to CHO-produced antibodies. Non-conventional chondrosarcoma; e.g., clear-cell, mesenchymal ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...
The purpose of this study is to evaluate the role of an antibody, called anti-PLA2R, in detecting disease in patients with membranous nephropathy (MN) who ...
Mayo Clinic expert answers questions about antibody testing for COVID-19 featured image. Featured News. Mayo Clinic expert answers questions about antibody ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.